Compared to warfarin, edoxaban was as effective -- or even more so -- in preventing stroke and blood clots, researchers said.

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

Emerging science and better blood management practices offer a chance to reduce blood usage and can be part of a ...

meaning there are not enough healthy red blood cells to deliver enough oxygen. This is particularly concerning for patients undergoing surgery because there is almost always some amount of blood loss ...

Poorly controlled blood pressure among key risk factors in rare but potentially lethal neck hematomas occurring after ...

Each year, there are thousands of people waiting for a kidney or liver transplant in the U.S. Some of those transplant ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

Shortly after Moira was diagnosed with a brain tumour, she made the decision that she wouldn’t have surgery. It was news that Cain struggled to accept but also didn’t have control over. With that, the ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

Patients who receive a heart valve replacement are well-known to be at a high risk for stroke, blood clots and deep vein thrombosis, especially during the weeks immediately after surgery. Current ...